Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.

Oncotherapy science (OTS) is“ to deliver cancer therapeutics and treatments with higher efficacy and fewer side effects to patients suffering from cancer as soon as possible, and to overcome the fight against cancer. Was established with the aim of OTS brought Professor Genomix (Science that handles genetic information systematically) as a pioneer in the medical field with Prof. Atsushi Nakamura (Director, Cancer Precision Medical Research Center, Institute of Cancer, Professor Emeritus, The University of Tokyo, Professor Emeritus of Chicago University) Joint research to identify target molecules suitable for cancer drug development based on comprehensive gene expression analysis, and promote research and development of small molecule drugs, cancer peptide vaccines and antibody drugs for those targets.

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

Voronoi, Inc. engages in the manufacture of novel kinase inhibitors and target protein degrader drugs. The company was founded on February 24, 2015 and is headquartered in Incheon, South Korea.

Korea Medical Science Institute Co., Ltd. is a South Korean private company that provides research development in biotechnology services.

The Korea Atomic Energy Research Institute (KAERI) in Daejeon, South Korea was established in 1959 as the sole professional research-oriented institute for nuclear power in South Korea, and has rapidly built a reputation for research and development in various fields. In 1995 KAERI designed and constructed the nation's first multipurpose research reactor, HANARO based on the Canadian MAPLE design. KAERI is dedicated to finding a wide range of uses for atomic energy. As examples, KAERI developed the world's first radiopharmaceutical "Milican injection" for treating liver cancer.

The National Institute of Advanced Industrial Science and Technology (AIST), led by President Chubachi, is a public research institution funded by the Japanese government to a large extent. The present AIST is a rather new research organization established in 2001. However, AIST and its predecessor organizations have been contributing to society through continuous advancement in technologies and support to Japanese industries since 1882. Headquarters of AIST are located in Tsukuba and Tokyo. AIST has over 40 autonomous research units in various innovative research fields, and the units are located at ten research bases and several sites (smaller than research bases) of AIST all over Japan. About 2300 researchers (about 2000 with tenure: about 80 from abroad) and a few thousands of visiting scientists, post-doctoral fellows, and students from home and abroad are working at AIST. About 650 permanent administrative personnel and many temporary staff support research works of AIST.

Activate Immunotherapy operates as a clinical-stage biopharmaceutical company. The firm discovers, develops, and commercializes Immunotherapies for the treatment of cancer. The company was founded by Habib Fakhrai and Emmet O’Neal III in 1997 and is headquartered in San Diego, CA.

Jiangsu Naique Bioengineering Technology Co., Ltd., established on 2014-11-10, Business scope includes technology research and development in the field of biomedicine,technology transfer,technical consulting,Technical service and achievement transformation;Pharmaceutical Intermediates,Plant extracts,food additives,Flavors and Fragrances,cosmetic,disinfectant,R & D and production of sanitary products;food(limit<food business license>The main business format and business items specified),sales of tea;Health and Weight Loss Services;Health massage service;beauty service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Sanofi Genzyme is the specialty care global business unit of Sanofi, focused on rare diseases, multiple sclerosis, immunology, and oncology. They help people with debilitating and complex conditions that are often difficult to diagnose and treat. They are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world. Genzyme became part of Sanofi in 2011. While continuing to focus on rare diseases, they also established ourselves as a leader in the field of multiple sclerosis. In 2016, their focus expanded to include Sanofi’s programs in oncology and immunology. Their approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Founded as Genzyme in Boston in 1981, they rapidly grew to become one of the world’s leading biotechnology companies, recognized for their pioneering development of treatments for rare genetic disorders and their innovative contributions to medical science and biomanufacturing.

G&E Herbal Biotechnology Co., Ltd. is engaged in the development, manufacture, and sale of novel botanic drugs, western & herbal medicines. It offers botanical anti-aging gliter series cosmetics, botanical healthcare G&E series product, hepato protective agent, botanical antila series gel, skin care products, food supplements and adult products. The company also provides biotechnological services. G&E Herbal Biotechnology was founded by Kuo Wha Kuo on August 6, 2002 and is headquartered in Tainan, Taiwan.

Genomictree Inc. is a company based out of South Korea.

Fujian Zhongke Biological Co., Ltd., established on 2015-12-28, Business scope includes general items:Natural science research and experimental development;Technology promotion and application services;Agricultural Science Research and Experimental Development;vegetable planting;fruit planting;Chinese herbal medicine planting;spice crops;tea planting;Bio-organic fertilizer research and development;Non-Major Crop Seed Production;Agricultural machinery manufacturing;Agricultural Machinery Sales;Manufacturing of lighting fixtures;Lighting Sales;food business(Only sell prepackaged food);Food Internet Sales(Selling prepackaged food);Primary processing of edible agricultural products(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license) licensed items:pharmaceutical production;Health food production;fertilizer production;food production;Production of tea products(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

immatics is a biopharmaceutical company focused on the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors. The company's customized Adoptive Cell Therapies (ACTengine) and antibody-like TCR Bispecifics are the two main product classes in the pipeline (TCER). With a focus on particularly difficult-to-treat solid malignancies, each therapy modality has unique characteristics to create the desired therapeutic impact for patients at various disease stages and with various types of tumors. immatics biotechnologies was established in 2000 by Hans Rammensee, Harpreet Singh, and Steffen Walter in Tübingen, Baden-Wurttemberg.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Shenyang Fuyang Pharmaceutical Technology Co., Ltd., established on 2016-11-17, Business scope includes drug research and development,retail;Drug R&D Technical Consulting,technology transfer,Technical Services;Business Management Consulting;Self-operated and agent import and export of various commodities and technologies,Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

Manufactures pharmaceuticals and diagnostic substances